Careers in Biotech: Future Opportunities in Health and Life Sciences
Content
Looking for new opportunities and pathways towards future success? How does a degree in health and life sciences connect with biotechnology?
Hosted by the UMass Amherst School of Public Health and Health Sciences and moderated by alumnus and Boston-based BioTech executive Imran Nasrullah '87, this exciting and cutting-edge career symposium will feature biotechnology professionals, entrepreneurs and talent seekers who are ready to open this world to our graduate students and recent alumni.
Enjoy an evening with a prominent keynote guest speaker and panelists from all aspects of biotech followed by socializing and networking over cocktails or mocktails and heavy hor d’oeuvres. Shaw Hall on the UMass Mount Ida campus, just 45 minutes from Boston, is a relaxing and beautiful place to spend the evening, easy to find and park.
This is a private and exclusive event created by our own SPHHS alumni working and innovating in this dynamic field of biotechnology in Boston. Eighty-eight percent of our alumni live and work in this city. Come and spend an evening at the Mount Ida campus and begin developing your networks.
Please register by August 6th.
Transportation from UMass Amherst
Round trip transportation is available from the UMass Amherst campus to the UMass Mount Ida campus for this event. Let us know if you are interested when completing your registration.
Agenda:
(in progress)
5:00 PM: Welcome and Opening Remarks: Imran Nasrullah '87
5:15 PM: Keynote Address: The Future of Biotech in Health and Life Sciences
6:00 PM: Panel Discussion: Biotech Careers for Master's and Doctoral Students
7:00-8:00 PM: Networking Reception to follow in Shaw Hall, Living Room
Moderator: Imran Nasrullah '87
Imran Nasrullah is an intrapreneur driving external innovation with entrepreneurs and possesses 25 years of business development and licensing, strategy, economic development and technology transfer experience. He is Chief Business Officer for Grove BioPharma, Inc. a Chicago-based biotechnology company focused on oncology and neurodegeneration. Previously, Imran was Vice President and U.S. Head of BD&L & Open Innovation at Bayer Pharmaceuticals; he was responsible for forging new business relationships with academia, biotech and venture capital for early access to technologies. Imran also led late-stage and in-market licensing deals across Bayer’s U.S. portfolio; he also created & leads several programs at Bayer centered on mentoring and partnering with early-stage life science companies.
Prior to Bayer, Imran worked for Boehringer Ingelheim in BD&L leading scouting and evaluation primarily in Boston and San Diego. Imran received Boehringer Ingelheim's distinguished President’s Award within two years of joining BI. He possesses extensive experience covering strategy, business development, alliance management, partnering and licensing activities in diagnostics, personalized medicine, therapeutics, and technology platforms. He holds a proven track record track record at blue-chip organizations like Boehringer Ingelheim, Genzyme Genetics (now LabCorp), Millennium Pharmaceuticals (Takeda), Dana Farber Cancer Center and Mayo Clinic. In the diversity of his experiences, Imran was also the Chief Business Officer for Massbio, where he successfully turned around Massbio into the most successful biotechnology state trade-association in the country; and launched several ground breaking mentoring and partnering programs that were later adopted by other state trade associations.
Imran is passionate about ecosystem development and new company creation; towards that end, he founded many innovative programs centered on life-science mentoring and partnering starting at Massbio, followed by Boehringer Ingelheim, and now at Bayer. Through his various programs, he has coached over 300 early stage companies over the past decade.
Imran earned his Bachelor's degree in Kinesiology from UMass Amherst in 1987. He subsequently received his Master of Science (M.S.) degree from the University of Colorado at Boulder and his Juris Doctor (J.D.) degree from Suffolk University Law School with an emphasis on intellectual property and licensing.